Importer of Controlled Substances Registration, 25335-25336 [2017-11388]

Download as PDF 25335 Federal Register / Vol. 82, No. 104 / Thursday, June 1, 2017 / Notices Dated: May 23, 2017. Louis J. Milione, Assistant Administrator. The company plans to manufacture small quantities of the listed controlled substance in bulk for distribution to its customers. [FR Doc. 2017–11383 Filed 5–31–17; 8:45 am] Dated: May 23, 2017. Louis J. Milione, Assistant Administrator. BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [FR Doc. 2017–11385 Filed 5–31–17; 8:45 am] BILLING CODE 4410–09–P Drug Enforcement Administration [Docket No. DEA–392] DEPARTMENT OF JUSTICE Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC ACTION: Drug Enforcement Administration [Docket No. DEA–392] Notice of application. Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before July 31, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on July 5, 2016, Chemtos, LLC, 14101 W. Highway 290, Building 2000B, Austin, Texas 78737–9331 applied to be registered as a bulk manufacturer for 3,4Methylenedioxymethamphetamine (7405), a basic class of controlled substance listed in schedule I. mstockstill on DSK30JT082PROD with NOTICES SUPPLEMENTARY INFORMATION: Importer of Controlled Substances Application: Cerilliant Corporation ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before July 3, 2017]. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before July 3, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of DATES: manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on April 6, 2017, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665–2402 applied to be registered as an importer of U–47700 (3,4-dichloro-N-[2dimethylamino)cyclohexyl]-Nmethylbenzamide) (9547), a basic class of controlled substance listed in schedule I. The company plans to import small quantities of the listed controlled substance for the manufacture of analytical reference standards and distribution to their research and forensic customers. Dated: May 25, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017–11387 Filed 5–31–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration ACTION: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. SUMMARY: Company FR docket Chattem Chemicals, Inc ................................................................................................................................. Anderson Brecon, Inc .................................................................................................................................... Hospira ........................................................................................................................................................... Myoderm ........................................................................................................................................................ Meridian Medical Technologies ..................................................................................................................... VerDate Sep<11>2014 18:32 May 31, 2017 Jkt 241001 PO 00000 Frm 00112 Notice of registration. Fmt 4703 Sfmt 4703 E:\FR\FM\01JNN1.SGM 81 81 82 82 82 FR FR FR FR FR 01JNN1 62177 71766 11241 13134 13135 Published September 8, 2016. October 18, 2016. February 21, 2017. March 9, 2017. March 9, 2017. 25336 Federal Register / Vol. 82, No. 104 / Thursday, June 1, 2017 / Notices Company FR docket Meda Pharmaceuticals, Inc ............................................................................................................................ Wildlife Laboratories, Inc ................................................................................................................................ Xcelience ........................................................................................................................................................ 82 FR 13137 82 FR 14914 82 FR 16420 The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies. Dated: May 23, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017–11388 Filed 5–31–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1121–NEW] Agency Information Collection Activities; Proposed eCollection eComments Requested; New Collection: Survey of State Attorney General Offices (SSAGO)—Cybercrime Overview of This Information Collection Bureau of Justice Statistics, Department of Justice. ACTION: 60-Day notice. AGENCY: The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until July 31, 2017. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection mstockstill on DSK30JT082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:32 May 31, 2017 Jkt 241001 instrument with instructions or additional information, please contact Suzanne Strong, Statistician, Prosecution and Judicial Statistics, Bureau of Justice Statistics, 810 Seventh Street NW., Washington, DC 20531 (email: Suzanne.M.Strong@usdoj.gov; telephone: 202–616–3666). SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. (1) Type of Information Collection: New collection. (2) The Title of the Form/Collection: Survey of State Attorney General Offices (SSAGO): Cybercrime. (3) The agency form number, if any, and the applicable component of the Department sponsoring the collection: No agency form number at this time. The applicable component within the Department of Justice is the Bureau of Justice Statistics, in the Office of Justice Programs. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Respondents will be state attorneys general or deputy attorneys within the state attorney general offices who work on cybercrime matters. PO 00000 Frm 00113 Fmt 4703 Sfmt 9990 Published March 9, 2017. March 23, 2017. April 4, 2017. Abstract: Among other responsibilities, the Bureau of Justice Statistics is charged with collecting data regarding the prosecution of crimes by state and federal offices. This survey will be directed towards state and territory attorney general offices regarding their jurisdiction over civil and criminal cybercrime matters. This is BJS’s second survey of state attorney general offices, but the first survey from the Survey of State Attorney General Offices (SSAGO) program. The survey collects data on types and numbers of cybercrime matters referred to the state attorney general offices, the sources of the referrals of cybercrime matters, types and numbers of cybercrime cases closed by state attorney general offices, civil and criminal defendants in cybercrime matters, sanctions and punishments of civil defendants found liable and criminal defendants found guilty, and participation in state and federal cybercrime task forces. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: An agency-level survey will be sent to approximately 56 state and territory attorney general offices. The expected burden placed on these respondents is about 65 minutes per respondent, including follow-up. (6) An estimate of the total public burden (in hours) associated with the collection: The total respondent burden is approximately 61 burden hours. If additional information is required contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., 3E.405A, Washington, DC 20530. Dated: May 26, 2017. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2017–11306 Filed 5–31–17; 8:45 am] BILLING CODE 4410–18–P E:\FR\FM\01JNN1.SGM 01JNN1

Agencies

[Federal Register Volume 82, Number 104 (Thursday, June 1, 2017)]
[Notices]
[Pages 25335-25336]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11388]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]

Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as importers
of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as importers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for these notices.

----------------------------------------------------------------------------------------------------------------
Company FR docket Published
----------------------------------------------------------------------------------------------------------------
Chattem Chemicals, Inc................... 81 FR 62177 September 8, 2016.
Anderson Brecon, Inc..................... 81 FR 71766 October 18, 2016.
Hospira.................................. 82 FR 11241 February 21, 2017.
Myoderm.................................. 82 FR 13134 March 9, 2017.
Meridian Medical Technologies............ 82 FR 13135 March 9, 2017.

[[Page 25336]]

Meda Pharmaceuticals, Inc................ 82 FR 13137 March 9, 2017.
Wildlife Laboratories, Inc............... 82 FR 14914 March 23, 2017.
Xcelience................................ 82 FR 16420 April 4, 2017.
----------------------------------------------------------------------------------------------------------------

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable basic classes of schedule I or II controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each company's
maintenance of effective controls against diversion by inspecting and
testing each company's physical security systems, verifying each
company's compliance with state and local laws, and reviewing each
company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed companies.

Dated: May 23, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-11388 Filed 5-31-17; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.